Leonteq Securities’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
Leonteq Securities's SRPT Position: Q3 2026 in Review
Leonteq Securities increased its Sarepta Therapeutics (SRPT) stake by 132% in Q3 2026, buying an estimated $144K and bringing the position to 13,539 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #461.
Leonteq Securities first reported a position in SRPT in Q4 2020 and has held it in 21 quarters since. The position peaked at $285K in Q4 2024. 299 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.
- Leonteq Securities held 13,539 shares of Sarepta Therapeutics worth $247K as of Q3 2026.
- Leonteq Securities bought 7,694 Sarepta Therapeutics shares in Q3 2026, an estimated $144K.
- Sarepta Therapeutics made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #461 holding.
- Leonteq Securities first reported a position in Sarepta Therapeutics in Q4 2020 and has held it in 21 quarters since.
- Leonteq Securities's Sarepta Therapeutics position peaked at $285K in Q4 2024.
- 299 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.